TUBEROUS SCLEROSIS COMPLEX (TSC)
Clinical trials for TUBEROUS SCLEROSIS COMPLEX (TSC) explained in plain language.
Never miss a new study
Get alerted when new TUBEROUS SCLEROSIS COMPLEX (TSC) trials appear
Sign up with your email to follow new studies for TUBEROUS SCLEROSIS COMPLEX (TSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cannabis oil trial aims to tame seizures in rare genetic disorder
Disease control Recruiting nowThis Phase 3 trial tests a full-spectrum cannabis extract (YCJ-01) in 84 people aged 2 to 65 with tuberous sclerosis complex (TSC) whose seizures have not been controlled by standard treatments. Participants will receive either the cannabis extract or a placebo for two months. Th…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX (TSC)
Phase: PHASE3 • Sponsor: Oils4Cure • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase trial tests a new drug called Sapu003, given with or without exemestane, in adults with advanced cancers that respond to mTOR pathways—including certain breast, kidney, liver, and neuroendocrine tumors. The main goal is to find the safest dose and check for side …
Matched conditions: TUBEROUS SCLEROSIS COMPLEX (TSC)
Phase: PHASE1 • Sponsor: SAPU NANO (US) LLC • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Study links gum health to rare kidney diseases
Knowledge-focused Recruiting nowThis study looks at gum disease in people with rare kidney disorders like Alport syndrome, Fabry disease, and tuberous sclerosis, as well as lupus. Researchers will compare 100 participants to those with chronic kidney disease and healthy controls. They aim to understand how comm…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX (TSC)
Sponsor: Stefan Lujinschi • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC